The core activity of RetinAI (Ikerian AG) is the development and provision of software solutions for medical image processing and analysis, particularly in the field of ophthalmology, with a focus on artificial intelligence (AI) and machine learning. The company's products, such as the DISCOVERY and UNITY platforms, support doctors and researchers in diagnosing and treating eye diseases, as well as conducting clinical trials.
AI-generated
Offering
Products & services
Industry:Research & Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Ophthalmology data and AI platform for collecting, harmonizing, analyzing and visualizing multimodal image and patient data; cloud-based, interoperable, and with CE/FDA-certified modules.
Pharma and Life Sciences Data Platform (Discovery UNITY)
Multimodal platform for data harmonization, aggregation and AI analysis for pharma and life sciences; supports research workflows, disease biomarker evaluation and secure collaboration.
Platform for Clinical Studies (Discovery for Clinical Studies)
Platform for capturing, managing and analyzing clinical study data from multiple sources; supports enrollment, endpoint analysis, monitoring and reading-center workflows.
Platform for Clinical Workflows (Discovery for Clinics)
CE-marked platform for ophthalmologists and optometrists for managing OCTs, fundus images and other files; with AI analysis, tele-ophthalmology and patient management.
Real-World Evidence Solutions
Solutions for real-world evidence in ophthalmology with data, analysis tools and support; used for clinical development, HEOR and commercialization.